Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.745 USD | +4.29% | -12.14% | +65.95% |
Apr. 12 | Lipocine Says LPCN 2401 Shows Improved Body Composition in Mid-Stage Trial | MT |
Apr. 11 | Top Premarket Gainers | MT |
Financials (USD)
Sales 2024 * | 2.03M | Sales 2025 * | - | Capitalization | 24.19M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | - | EV / Sales 2024 * | 11.9 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.05
x | P/E ratio 2025 * |
-
| Employees | 17 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.96% |
1 day | +2.48% | ||
1 week | -16.36% | ||
Current month | -12.50% | ||
1 month | +3.41% | ||
3 months | +18.80% | ||
6 months | +88.80% | ||
Current year | +63.08% |
Managers | Title | Age | Since |
---|---|---|---|
Mahesh Patel
CEO | Chief Executive Officer | 67 | 96-12-31 |
Anthony DelConte
CTO | Chief Tech/Sci/R&D Officer | 66 | - |
Krista Fogarty
AUD | Comptroller/Controller/Auditor | 56 | 18-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Dana Ono
BRD | Director/Board Member | 71 | 14-01-05 |
Mahesh Patel
CEO | Chief Executive Officer | 67 | 96-12-31 |
John W. Higuchi
BRD | Director/Board Member | 56 | 12-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 4.63 | +1.76% | 18 133 |
24-04-25 | 4.55 | +2.48% | 7,982 |
24-04-24 | 4.44 | -7.50% | 66,373 |
24-04-23 | 4.8 | -5.33% | 76,675 |
24-04-22 | 5.07 | -3.80% | 21,546 |
Delayed Quote Nasdaq, April 25, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.08% | 24.19M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.87% | 22.02B | |
-17.84% | 20.9B | |
-8.91% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- LPCN Stock